All News #Library
Rare Diseases
Elevar offers $500M biobucks for Relay`s rare cancer asset
03 Dec 2024 //
FIERCE BIOTECH
Elevar Therapeutics Gets EU Orphan Drug Designation For HCC Therapy
01 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support